17β-estradiol potentiates endothelium-dependent nitric oxide- and hyperpolarization-mediated relaxations in blood vessels of male but not female apolipoprotein-E deficient mice

Vascular Pharmacology

Volumn 71, Issue , 2015, Pages 166-173

  Kong, Billy W C ^a   Vanhoutte, Paul M ^a   Man, Ricky Y K ^a   Leung, Susan W S ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

17 estradiol; Aging; Endothelial dysfunction; Endothelium derived hyperpolarization; Hyperlipidemia; Reactive oxygen species

Indexed keywords

APOCYNIN; APOLIPOPROTEIN E; CALCIUM ACTIVATED POTASSIUM CHANNEL; CHOLESTEROL; ESTRADIOL; ESTROGEN; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTERIAL PRESSURE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM DEPENDENT HYPERPOLARIZATION; ESTRADIOL BLOOD LEVEL; ESTROGEN BLOOD LEVEL; FEMALE; HYPERPOLARIZATION; IN VITRO STUDY; LIPID BLOOD LEVEL; MALE; MESENTERIC ARTERY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; SUPERIOR MESENTERIC ARTERY; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; DEFICIENCY; DOSE RESPONSE; DRUG EFFECTS; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY; SEXUAL DEVELOPMENT; VASCULAR ENDOTHELIUM; VASODILATATION;

ANIMALS; APOLIPOPROTEINS E; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ESTRADIOL; FEMALE; MALE; MICE; MICE, KNOCKOUT; NITRIC OXIDE; SEX CHARACTERISTICS; VASODILATION;

EID: 84937969132     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2015.02.009     Document Type: Article

References (48)

1. Lee H.Y., Oh B.H. Aging and arterial stiffness. Circ J 2010, 74:2257-2262.
2. Lerner D.J., Kannel W.B. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 1986, 111:383-390.
3. Barrett-Connor E. Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture. Circulation 1997, 95:252-264.
4. van der Mooren M.J., Mijatovic V., van Baal W.M., Stehouwer C.D. Hormone replacement therapy in postmenopausal women with specific risk factors for coronary artery disease. Maturitas 1998, 30:27-36.
5. Le Gal G., Gourlet V., Hogrel P., Plu-Bureau G., Touboul P.J., Scarabin P.Y. Hormone replacement therapy use is associated with a lower occurrence of carotid atherosclerotic plaques but not with intima-media thickness progression among postmenopausal women. The vascular aging (EVA) study. Atherosclerosis 2003, 166:163-170.
6. Bourghardt J., Bergström G., Krettek A., Sjöberg S., Borén J., Tivesten A. The endogenous estradiol metabolite 2-methoxyestradiol reduces atherosclerotic lesion formation in female apolipoprotein E-deficient mice. Endocrinology 2007, 148:4128-4132.
7. Resanovic I., Rizzo M., Zafirovic S., Bjelogrlic P., Perovic M., Savic K., Patti A.M., Isenovic R.E. Anti-atherogenic effects of 17β-estradiol. Horm Metab Res 2013, 45:701-708.
8. Rifici V.A., Khachadurian A.K. The inhibition of low-density lipoprotein oxidation by 17-beta estradiol. Metabolism 1992, 41:1110-1114.
9. + channels. Circ Res 1996, 79:1024-1030.
10. 2+ and ecNOS activity. Am J Physiol 1999, 276:H961-H969.
11. White R.M., Rivera C.O., Davison C.A. Nitric oxide-dependent and -independent mechanisms account for gender differences in vasodilation to acetylcholine. J Pharmacol Exp Ther 2000, 292:375-380.
12. Xu R., Sowers J.R., Skafar D.F., Ram J.L. Hydrocortisone modulates the effect of estradiol on endothelial nitric oxide synthase expression in human endothelial cells. Life Sci 2001, 69:2811-2817.
13. Novensa L., Selent J., Pastor M., Sandberg K., Heras M., Dantas A.P. Equine estrogens impair nitric oxide production and endothelial nitric oxide synthase transcription in human endothelial cells compared with the natural 17beta-estradiol. Hypertension 2010, 56:405-411.
14. Wagner A.H., Schroeter M.R., Hecker M. 17beta-estradiol inhibition of NADPH oxidase expression in human endothelial cells. FASEB J 2001, 15:2121-2130.
15. Florian M., Lu Y., Angle M., Magder S. Estrogen induced changes in Akt-dependent activation of endothelial nitric oxide synthase and vasodilation. Steroids 2004, 69:637-645.
16. Schulz E., Anter E., Zou M.H., Keaney J.F. Estradiol-mediated endothelial nitric oxide synthase association with heat shock protein 90 requires adenosine monophosphate-dependent protein kinase. Circulation 2005, 111:3473-3480.
17. + is an endothelium-derived hyperpolarizing factor in rat arteries. Nature 1998, 396:269-272.
18. Félétou M., Vanhoutte P.M. Endothelium-derived hyperpolarizing factor: where are we now?. Arterioscler Thromb Vasc Biol 2006, 26:1215-1225.
19. Félétou M., Köhler R., Vanhoutte P.M. Endothelium-derived vasoactive factors and hypertension: possible roles in pathogenesis and as treatment targets. Curr Hypertens Rep 2010, 12:267-275.
20. Gerber R.T., Anwar M.A., Poston L. Enhanced acetylcholine induced relaxation in small mesenteric arteries from pregnant rats: an important role for endothelium-derived hyperpolarizing factor (EDHF). Br J Pharmacol 1998, 125:455-460.
21. Liu M.Y., Hattori Y., Fukao M., Sato A., Sakuma I., Kanno M. Alterations in EDHF-mediated hyperpolarization and relaxation in mesenteric arteries of female rats in long-term deficiency of oestrogen and during oestrus cycle. Br J Pharmacol 2001, 132:1035-1046.
22. Xu H.L., Ye S., Baughman V.L., Feinstein D.L., Pelligrino D.A. The role of the glia limitans in ADP-induced pial arteriolar relaxation in intact and ovariectomized female rats. Am J Physiol Heart Circ Physiol 2005, 288:H382-H388.
23. Zhang S.H., Reddick R.L., Piedrahita J.A., Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992, 258:468-471.
24. Sankaranarayanan A., Raman G., Busch C., Schultz T., Zimin P.I., Hoyer J., Köhler R., Wulff H. Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure. Mol Pharmacol 2009, 75:281-295.
25. Gluais P., Edwards G., Weston A.H., Falck J.R., Vanhoutte P.M., Félétou M. Role of SK(Ca) and IK(Ca) in endothelium-dependent hyperpolarizations of the guinea-pig isolated carotid artery. Br J Pharmacol 2005, 144:477-485.
26. Zhao Y., Vanhoutte P.M., Leung S.W. Endothelial nitric oxide synthase-independent release of nitric oxide in the aorta of the spontaneously hypertensive rat. J Pharmacol Exp Ther 2013, 344:15-22.
27. Sealey J.E., Itskovitz-Eldor J., Rubattu S., James G.D., August P., Thaler I., Levron J., Laragh J.H. Estradiol- and progesterone-related increases in the renin-aldosterone system: studies during ovarian stimulation and early pregnancy. J Clin Endocrinol Metab 1994, 79:258-264.
28. Schlüter T., Steinbach A.C., Steffen A., Rettig R., Grisk O. Apocynin-induced vasodilation involves rho kinase inhibition but not NADPH oxidase inhibition. Cardiovasc Res 2008, 80:271-279.
29. Serban D.N., Nilius B., Vanhoutte P.M. The endothelial saga: the past, the present, the future. Pflugers Arch - Eur. J Physiol 2010, 459:787-792.
30. + channel in porcine coronary artery endothelium: relevance to EDHF. Br J Pharmacol 2002, 135:1133-1143.
31. Wu C.C., Chen S.J., Yen M.H. Different responses to acetylcholine in the presence of nitric oxide inhibitor in rat aortae and mesenteric arteries. Clin Exp Pharmacol Physiol 1993, 20:405-412.
32. Bobadilla R.A., Henkel C.C., Henkel E.C., Escalante B., Hong E. Possible involvement of endothelium-derived hyperpolarizing factor in vascular responses of abdominal aorta from pregnant rats. Hypertension 1997, 30:596-602.
33. Castillo C., Reyes G., Escalante B., López P., Castillo E.F. Endothelium-dependent vasodilatation in rat aorta is mainly mediated by nitric oxide. Proc West Pharmacol Soc 1997, 40:39-40.
34. Meyrelles S.S., Peotta V.A., Pereira T.M., Vasquez E.C. Endothelial dysfunction in the apolipoprotein E-deficient mouse: insights into the influence of diet, gender and aging. Lipids Health Dis 2011, 10:211.
35. Cola M.S., Gava A.L., Meyrelles S.S., Vasquez E.C. Endothelial dysfunction of resistance vessels in female apolipoprotein E-deficient mice. Lipids Health Dis 2010, 9:51.
36. Freudenberger T., Oppermann M., Heim H.K., Mayer P., Kojda G., Schrör K., Fischer J.W. Proatherogenic effects of estradiol in a model of accelerated atherosclerosis in ovariectomized ApoE-deficient mice. Basic Res Cardiol 2010, 105:479-486.
37. Reckelhoff J.F., Zhang H., Srivastava K. Gender differences in development of hypertension in spontaneously hypertensive rats: role of the renin-angiotensin system. Hypertension 2000, 35:480-483.
38. Miyazaki-Akita A., Hayashi T., Ding Q.F., Shiraishi H., Nomura T., Hattori Y., Iguchi A. 17beta-estradiol antagonizes the down-regulation of endothelial nitric-oxide synthase and GTP cyclohydrolase I by high glucose: relevance to postmenopausal diabetic cardiovascular disease. J Pharmacol Exp Ther 2007, 320:591-598.
39. Dantas A.P., Tostes R.C., Fortes Z.B., Costa S.G., Nigro D., Carvalho M.H. In vivo evidence for antioxidant potential of estrogen in microvessels of female spontaneously hypertensive rats. Hypertension 2002, 39:405-411.
40. Takenouchi Y., Kobayashi T., Matsumoto T., Kamata K. Gender differences in age-related endothelial function in the murine aorta. Atherosclerosis 2009, 206:397-404.
41. Panza J.A. Endothelial dysfunction in essential hypertension. Clin Cardiol 1997, 20. [II-26-33].
42. Strehlow K., Rotter S., Wassmann S., Adam O., Grohé C., Laufs K., Böhm M., Nickenig G. Modulation of antioxidant enzyme expression and function by estrogen. Circ Res 2003, 93:170-177.
43. Stokes K.Y., Cooper D., Tailor A., Granger D.N. Hypercholesterolemia promotes inflammation and microvascular dysfunction: role of nitric oxide and superoxide. Free Radic Biol Med 2002, 33:1026-1036.
44. Li J.M., Shah A.M. Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. Am J Physiol Regul Integr Comp Physiol 2004, 287:R1014-R1030.
45. Radi R., Beckman J.S., Bush K.M., Freeman B.A. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J Biol Chem 1991, 266:4244-4250.
46. Jin R.C., Loscalzo J. Vascular nitric oxide: formation and function. J Blood Med 2010, 2010:147-162.
47. Matsumoto T., Miyamori K., Kobayashi T., Kamata K. Apocynin normalizes hyperreactivity to phenylephrine in mesenteric arteries from cholesterol-fed mice by improving endothelium-derived hyperpolarizing factor response. Free Radic Biol Med 2006, 41:1289-1303.
48. Dal-Ros S., Oswald-Mammosser M., Pestrikova T., Schott C., Boehm N., Bronner C., Chataigneau T., Gény B., Schini-Kerth V.B. Losartan prevents portal hypertension-induced, redox-mediated endothelial dysfunction in the mesenteric artery in rats. Gastroenterology 2010, 138:1574-1584.